Clinical Trial Update: Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials [Phase 4]

View source ↗

Summary

Phase 4 multicenter randomized trial comparing moxifloxacin to ofloxacin plus metronidazole for uncomplicated pelvic inflammatory disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Inflammatory Disease

Drugs mentioned

• METRONIDAZOLE (Metronidazole)
• Moxifloxacin (moxifloxacin)
• OFLOXACIN (OFLOXACIN)

Snippet

Sponsor: Istanbul Bakirkoy Maternity and Children Diseases Hospital | Conditions: Pelvic Inflammatory Disease | Phase 4 | Status: COMPLETED